Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Box 359911, Harborview Medical Center, 325 Ninth Ave, Seattle, WA 98104-2499, USA.
J Psychoactive Drugs. 2012 Jul-Aug;44(3):266-73. doi: 10.1080/02791072.2012.705065.
The co-occurring disorders quadrant model has been used as a framework for characterizing the heterogeneity in persons with low- and high-severity substance use and psychiatric disorders. This study investigated the validity and stability of the quadrant model in 155 adults who presented to one county hospital with psychiatric, substance use, or medical complaints. Quadrant placement was defined using data that is routinely gathered in clinical care or available in administrative data sets (i.e., substance dependence diagnosis, Global Assessment of Functioning scores). Fifty-four percent (n = 84) of study participants were categorized into quadrant IV (high-severity psychiatric/substance use), followed by quadrant I (low-severity psychiatric/substance use) (n = 32, 21%), quadrant II (high-severity psychiatric & low-severity substance use) (n = 25, 16%), and quadrant III (low-severity psychiatric & high-severity substance use) (n = 14, 9%). Quadrant placement was correlated with psychiatric and/or substance use diagnoses, psychiatric symptom severity, drug/alcohol toxicology and psychiatric and substance use health utilization, supporting the concurrent validity of the model. Initial quadrant placement was correlated with validity measures administered at three-month follow-up supporting predictive validity of the model. Initial and follow-up quadrant placement was significantly correlated suggesting stability of the quadrant model. Data support the validity of the quadrant model for application in clinical and administrative purposes.
共病障碍象限模型被用作描述低严重度和高严重度物质使用和精神障碍患者异质性的框架。本研究调查了该模型在 155 名因精神、物质使用或医疗问题到一家县医院就诊的成年人中的有效性和稳定性。象限的定位是使用在临床护理中常规收集或在行政数据集(即物质依赖诊断、总体功能评估评分)中可用的数据来定义的。54%(n=84)的研究参与者被归类为象限 IV(高严重度精神/物质使用),其次是象限 I(低严重度精神/物质使用)(n=32,21%)、象限 II(高严重度精神和低严重度物质使用)(n=25,16%)和象限 III(低严重度精神和高严重度物质使用)(n=14,9%)。象限的定位与精神和/或物质使用诊断、精神症状严重程度、药物/酒精毒理学以及精神和物质使用健康利用相关,支持该模型的同时效度。初始象限定位与在三个月随访时进行的有效性测量相关,支持该模型的预测效度。初始和随访象限定位显著相关,表明象限模型具有稳定性。数据支持象限模型在临床和行政用途中的有效性。